NONCONTIGUOUS STAGE II MANTLE CELL LYMPHOMA

Clinical trials for NONCONTIGUOUS STAGE II MANTLE CELL LYMPHOMA explained in plain language.

Never miss a new study

Get alerted when new NONCONTIGUOUS STAGE II MANTLE CELL LYMPHOMA trials appear

Sign up with your email to follow new studies for NONCONTIGUOUS STAGE II MANTLE CELL LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

New strategy aims to tame dangerous virus after cancer transplant

Disease control Ongoing

This study is testing a personalized plan to manage cytomegalovirus (CMV), a common and potentially serious infection, in patients who have received a donor stem cell transplant for blood cancers or disorders. The plan involves closely monitoring the virus level and the patient's…

Matched conditions: NONCONTIGUOUS STAGE II MANTLE CELL LYMPHOMA

Sponsor: City of Hope Medical Center • Aim: Disease control

Last updated Mar 16, 2026 15:26 UTC

NONCONTIGUOUS STAGE II MANTLE CELL LYMPHOMA

Get alerted when new NONCONTIGUOUS STAGE II MANTLE CELL LYMPHOMA trials appear

New strategy aims to tame dangerous virus after cancer transplant